Search

Purpose: Irinotecan metabolism, irinotecan pharmacogenetic research, and the role of genetic testing before administration of the drug are reviewed., Summary: Irinotecan is approved worldwide for the treatment of metastatic colorectal cancer but causes dose-limiting neutropenia and diarrhea. When severe, these can lead to dehydration, infection, patient discomfort, additional medication requirements, hospitalization, and death. The identification of predictive markers in irinotecan therapy has been a significant goal of pharmacogenetic research. The labeling of irinotecan was recently changed and now includes a warning of greater neutropenia risk in patients with reduced activity in the drug-metabolizing enzyme uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1). A known marker of reduced UGT1A1 activity is the genetic variant UGT1A1*28. Numerous studies have demonstrated the effects of genetic factors, especially UGT1A1*28, that contribute to interpatient variability in irinotecan pharmacokinetics and toxicity. Irinotecan's new labeling recommends that clinicians consider reducing the dosage of irinotecan in patients homozygous for UGT1A1*28., Conclusion: At least part of the interpatient variability of irinotecan toxicity can be explained by the UGT1A1*28 polymorphism. Patients who are homozygous for the UGT1A1*28 allele have an increased risk of developing severe neutropenia when receiving irinotecan, especially the 300-350- mg/m2 regimen. A molecular assay is now available to identify the at-risk subgroup and should be used by health care professionals to help guide irinotecan-treatment decisions.

Single in-frame amber (UAG) codons are found in the genes encoding MtmB, MtbB, or MttB, the methyltransferases initiating methane formation from monomethylamine, dimethylamine, or trimethylamine, respectively, in certain Archaea. The crystal structure of MtmB demonstrated that the amber codon codes for pyrrolysine, the 22nd genetically encoded amino acid found in nature. Previous attempts to visualize the amber-encoded residue by mass spectrometry identified only lysine, leaving information on the existence and structure of pyrrolysine resting entirely on crystallography of a single protein. Here we report successful mass spectral characterization of naturally occurring pyrrolysine and the first demonstration of the amber-encoded residue in proteins other than MtmB. The sequencing of chymotryptic fragments from acetonitrile-denatured proteins by tandem mass spectrometry revealed the mass of the amber-encoded residue in MtmB, MtbB, and MttB as 237.2 +/- 0.2 Da. Fourier transform ion cyclotron resonance mass spectrometry produced an accurate measurement for the pyrrolysyl-residue as 237.1456 Da, within error limits of the predicted mass based on the empirical formula C(12)H(19)N(3)O(2). These measurements support the structure of pyrrolysine in MtmB as 4-methylpyrroline-5-carboxylate in amide linkage with the (epsilon)N of lysine but not the alternative structure in which the 4-substituent of the pyrroline ring is an amine group. The presence of pyrrolysine with statistically identical mass in all three methyltransferases is in keeping with the proposed direct incorporation of pyrrolysine into protein during translation of the UAG codon and suggests that MtbB and MttB may exploit the unusual electrophilicity of pyrrolysine during catalysis.

We have studied the matrix photolysis of 2,4,6-triazido-1,3,5-triazine (cyanuric triazide, 1). Stepwise generation of the corresponding mononitrene, dinitrene, and trinitrene was observed by matrix IR and electron paramagnetic resonance (EPR) spectroscopy. The generated species were identified by comparison of their matrix IR spectra with density functional theory (DFT) computational results. The generation of 2,4,6-trinitreno-1,3,5-triazine with a septet ground state was confirmed for the first time by matrix EPR spectroscopy. The trinitrene readily decomposed into three NCN molecules upon further photoirradiation. This process was also confirmed by matrix EPR spectroscopy.

The synthesis of three novel nonlinear optical (NLO) chromophores with threefold symmetry, namely 1,3,5-tris(4-N,N-diethylaminophenyl)-2,4,6-tris(4-nitrophenyl)benzene (3), 1,3,5-tris(4-N,N-dihexylaminophenylbutadiynyl)-2,4,6-tris(4-nitrophenyl)benzene (13) and 1,3,5-tris(4-N,N-dihexylaminophenylethynyl)-2,4,6-tris(4-nitrophenylethynyl)benzene (4 b), is reported. We used the [Co(2)(CO)(8)]-catalysed trimerisation of 4-N,N-diethylamino-4'-nitrotolane (5) to prepare 3. The trimerisation experiment carried out with 1-(4-N,N-diethylaminophenyl)-6-(4-N,N-nitrophenyl)hexatriyne (6) and [Rh(PPh(3))(3)Cl] afforded 13. A stepwise approach was used to prepare 4 b. 1,3,5-Trichloro-2,4,6-triiodobenzene (8 b) was coupled with 4-nitrophenyl-acetylene (14) under Pd(0) catalysis to yield 1,3,5-trichloro-2,4,6-tris(4-nitrophenylethynyl)benzene (15). The coupling reaction of 15 with 4-N,N-dihexylaminophenylethynyltributylstannane (21) led to 4 b. X-ray investigations on 3, 4 b and 13 confirmed the structural assignments and revealed that the peripheral aryl rings in 4 b are less twisted around the connecting bonds than in 3 and 13. A large second-order polarisability (beta) of 4 b relative to 3 and 13 was determined by hyper-Rayleigh scattering (HRS). Compound 4 b represents an NLO chromophore with second-order polarisabily among the highest obtained so far for two-dimensional nondipolar NLO chromophores.

The syntheses and the electrochemical behavior of the monomeric peralkylated hexaamino(1,3)metacyclophane 4, the dimeric dodecaamino(1,3)cyclophane 5a, and the dodecaamino(1,3,5)cyclophane 6 are described. Electrochemical measurements show that the hexaaminobenzene units in 4 and 5a undergo an unusually slow two-electron transfer attributed to the deformation of the rings into bis-cyanine cations when oxidized to the respective dication. Further oxidations to tri-, tetra-, and hexacationic units occur at more positive potentials. In the dimeric structures, no interaction between the rings can be seen in the (1,3)cyclophane, but strong interaction for the (1,3,5)cyclophane is observed.

The X-ray structures of 4,10-di-tert-butyl-5,9-diisopropyl-4,5,9,10-tetraazatetracyclo[6.2.2.2(3,6)]tetradecane (s4iPr) and its 4,9-di-tert-butyl-5,10-diisopropyl isomer (a4iPr) are reported. Both compounds are in conformations having their in-N-alkyl groups (directed toward the central CH-CH bond of the molecule) anti to each other, as expected from previous work. The principal feature of interest is that one in-isopropyl group in each compound is in an eclipsed conformation, NN,C(alpha)Me twist angle -0.5(5) degrees for s4iPr and -6.4(4) degrees for a4iPr. Low energy (somewhat less) eclipsed in-isopropyl conformations are predicted by both molecular mechanics (MM2) and semiempirical quantum mechanical (AM1) calculations. The asymmetry of the potentially C(2) symmetric a4iPr because the two in-isopropyl groups are in different rotamers is apparently not a result of crystal packing forces, because a conformation with different isopropyl rotamers is the more stable one by at least 1.0 kcal/mol in solution, determined by (13)C-NMR spectroscopy. This result is not predicted by either calculation method. The "monomer", 2-tert-butyl-3-isopropyl-2,3-diazabicyclo[2.2.2]octane (3), proves to be a poor model for the conformations of 4iPr.